Search

everythinglearnresearchcommunity

for

Search:↓

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Lespedeza cuneata extract may help treat enlarged prostate.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

AI and AR are improving cosmetic dermatology but face challenges like data quality and ethical concerns.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Finasteride may improve prostate cancer treatment outcomes.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.